In this episode, Dr Jonathan O’Keefe, CEO of Machine Medicine joins Nick to discuss Machine Medicine’s innovative medical device in neuromodulation. In the episode, Dr O’Keefe outlines his transition from the NHS to startup CEO and along with Nick, they tackle the ethical limits of Neuromodulation.

Dr O’Keeffe first studied philosophy where he became interested in the interface between artificial and natural intelligence. Subsequently, he trained as a medical doctor and practised for several years while undertaking an MSc in machine learning at UCL and completing a PhD in computational neuroscience at Cambridge. He then retired from clinical practice to start Machine Medicine, a company utilising computer vision to measure physical impairment or disability. Machine Medicine currently focuses on Parkinson’s disease and is being deployed in numerous clinical trials, both commercial and non-commercial.

In this episode Dr Rob Hague joins Nick, to discuss the growth of Cydar in developing a product that utilizes computer vision and cloud computing for surgical guidance. Key in this episode is Rob’s explanation of rendering and visualization techniques they use and the challenges they first faced when they had to use standards from 1997.

Rob Hague is the CTO of Cydar Medical, a UK startup using computer vision and cloud computing to provide advanced surgical guidance. He’s worked in both research and product development, ranging from user interfaces and ubiquitous computing to low- level application infrastructure and algorithm implementation.

We were really lucky to be joined by Dr. Marc Goldfinger from Perspectum in Episode 2 of Life Sci AI: The Podcast series. During the episode, Marc expertly outlines the products he has been involved in and the steps Perspectum are taking to understand what happens to our internal organs post Covid-19.

Dr. Marc Goldfinger is currently working as a product specialist focusing on product development and commercialisation for Perspectum’s new suite of medical devices. Marc has over 15 years’ experience in biomarker development in research and product development, with a keen focus on pathology, imaging and neurodegenerative disorders. More recently, Marc has focused on bridging different imaging modalities and biomarkers to improve disease assessment in hepatobiliary and gastrointestinal conditions.

In Episode 1 of Life Sci AI: The Podcast series, Dr. Olivier